E-Qure is the developer of the Bioelectrical Signal Therapy (BST) Device, which treats wounds via electrical stimulation.The BST Device stimulates blood flow and oxygen in order to induce local cell regeneration and promote wound healing.
The companys technology is designed to accelerate wound healing by imitating the natural electrical current that occurs in injured skin on the human body. The BST Device uses electrodes affixed on opposing sides of the wound to emit an electrical field and mimic the electrochemical physiology principle, inducing local cell regeneration.
The BST Device is positioned to treat very severe wounds, including pressure ulcers, diabetic ulcers, and venous ulcers.The product is targeted toward the treatment of chronic wounds in hospitals, nursing homes, and home-care settings.
Cumulative Funding Raised Over Time ($)
Employees Over Time
E-Qure Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Jun 1, 2017
www.prnewswire.com
E-QURE Was Issued a New Research Report
#Investment
Feb 24, 2017
www.prnewswire.com
E-QURE's BST Device for Chronic Wound Care Receives Marketing Approval in Israel